Your Top 10 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

Priya Rastogi, Joyce O’Shaughnessy, Miguel Martín, Frances M. Boyle, Javier Cortés, Hope S. Rugo and 17 more

Rank
8 of 493
Percentile
top 1.7%
Where
Journal of Clinical Oncology, 2024
Citations
230

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.